IN202041055641A - - Google Patents

Download PDF

Info

Publication number
IN202041055641A
IN202041055641A IN202041055641A IN202041055641A IN202041055641A IN 202041055641 A IN202041055641 A IN 202041055641A IN 202041055641 A IN202041055641 A IN 202041055641A IN 202041055641 A IN202041055641 A IN 202041055641A IN 202041055641 A IN202041055641 A IN 202041055641A
Authority
IN
India
Application number
IN202041055641A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN202041055641A priority Critical patent/IN202041055641A/en
Publication of IN202041055641A publication Critical patent/IN202041055641A/en
Priority to EP21909726.8A priority patent/EP4211620A4/en
Priority to PCT/IN2021/051128 priority patent/WO2022137251A1/en
Priority to US18/250,190 priority patent/US20230395191A1/en
Priority to ZA2023/04311A priority patent/ZA202304311B/en

Links

Classifications

    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00Machine learning
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10Ploidy or copy number detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10Sequence alignment; Homology search

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Theoretical Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Data Mining & Analysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Software Systems (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Computing Systems (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Bioethics (AREA)
  • Databases & Information Systems (AREA)
  • Medicinal Chemistry (AREA)
  • Primary Health Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN202041055641A 2020-12-21 2020-12-21 IN202041055641A (cg-RX-API-DMAC7.html)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IN202041055641A IN202041055641A (cg-RX-API-DMAC7.html) 2020-12-21 2020-12-21
EP21909726.8A EP4211620A4 (en) 2020-12-21 2021-11-30 Drug resistance of target strains of a pathogen
PCT/IN2021/051128 WO2022137251A1 (en) 2020-12-21 2021-11-30 Drug resistance of target strains of a pathogen
US18/250,190 US20230395191A1 (en) 2020-12-21 2021-11-30 Drug resistance of target strains of a pathogen
ZA2023/04311A ZA202304311B (en) 2020-12-21 2023-04-11 Drug resistance of target strains of a pathogen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN202041055641A IN202041055641A (cg-RX-API-DMAC7.html) 2020-12-21 2020-12-21

Publications (1)

Publication Number Publication Date
IN202041055641A true IN202041055641A (cg-RX-API-DMAC7.html) 2021-11-19

Family

ID=82158562

Family Applications (1)

Application Number Title Priority Date Filing Date
IN202041055641A IN202041055641A (cg-RX-API-DMAC7.html) 2020-12-21 2020-12-21

Country Status (5)

Country Link
US (1) US20230395191A1 (cg-RX-API-DMAC7.html)
EP (1) EP4211620A4 (cg-RX-API-DMAC7.html)
IN (1) IN202041055641A (cg-RX-API-DMAC7.html)
WO (1) WO2022137251A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202304311B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023223354A1 (en) * 2022-05-20 2023-11-23 Aarogyaai Innovations Pvt. Ltd. Novel mutations for determining drug resistance in tuberculosis treatment and implementations thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115631870B (zh) * 2022-11-29 2023-05-19 中国兽医药品监察所 兽医病原耐药快速鉴定应用平台
WO2024116201A1 (en) * 2022-11-29 2024-06-06 Aarogyaai Innovations Pvt. Ltd. Classification of lineages and sub-lineages of pathogens
CN116189919B (zh) * 2023-04-20 2023-07-14 杭州迪安医学检验中心有限公司 一种微生物药敏的计算机分析方法、分析系统及其应用
CN119851774A (zh) * 2025-03-20 2025-04-18 南方医科大学 一种基于用户特征分析的肺癌耐药性预测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010313228B2 (en) * 2009-10-30 2014-05-29 Biogenic Innovations, Llc Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms
MX345230B (es) * 2010-02-24 2017-01-20 The Broad Inst Inc * Metodos para diagnosticar patogenos de enfermedad infecciosa y su sensibilidad a farmacos.
CA3048246A1 (en) * 2016-12-28 2018-07-05 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
WO2020046801A1 (en) * 2018-08-27 2020-03-05 The Broad Institute, Inc. COMPOSITIONS AND METHODS FOR DETECTING ANTIBIOTIC RESPONSIVE mRNA EXPRESSION SIGNATURES AND USES THEREOF
CN120174057A (zh) * 2019-05-31 2025-06-20 I·A·路易斯 微生物的代谢组学表征

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023223354A1 (en) * 2022-05-20 2023-11-23 Aarogyaai Innovations Pvt. Ltd. Novel mutations for determining drug resistance in tuberculosis treatment and implementations thereof

Also Published As

Publication number Publication date
US20230395191A1 (en) 2023-12-07
ZA202304311B (en) 2023-11-29
WO2022137251A1 (en) 2022-06-30
EP4211620A4 (en) 2024-11-20
EP4211620A1 (en) 2023-07-19

Similar Documents

Publication Publication Date Title
BR112023005462A2 (cg-RX-API-DMAC7.html)
BR112023012656A2 (cg-RX-API-DMAC7.html)
BR112021014123A2 (cg-RX-API-DMAC7.html)
BR112023009656A2 (cg-RX-API-DMAC7.html)
BR112022009896A2 (cg-RX-API-DMAC7.html)
BR112021017747A2 (cg-RX-API-DMAC7.html)
BR112022024743A2 (cg-RX-API-DMAC7.html)
BR112022026905A2 (cg-RX-API-DMAC7.html)
BR112023011738A2 (cg-RX-API-DMAC7.html)
BR112023004146A2 (cg-RX-API-DMAC7.html)
BR112023006729A2 (cg-RX-API-DMAC7.html)
BR102021018859A2 (cg-RX-API-DMAC7.html)
BR102021015500A2 (cg-RX-API-DMAC7.html)
BR102021007058A2 (cg-RX-API-DMAC7.html)
BR102020022030A2 (cg-RX-API-DMAC7.html)
BR112023016292A2 (cg-RX-API-DMAC7.html)
BR112023011539A2 (cg-RX-API-DMAC7.html)
BR112023011610A2 (cg-RX-API-DMAC7.html)
BR112023008976A2 (cg-RX-API-DMAC7.html)
BR102021020147A2 (cg-RX-API-DMAC7.html)
BR102021018926A2 (cg-RX-API-DMAC7.html)
BR102021018167A2 (cg-RX-API-DMAC7.html)
BR102021017576A2 (cg-RX-API-DMAC7.html)
BR102021016837A2 (cg-RX-API-DMAC7.html)
BR102021016551A2 (cg-RX-API-DMAC7.html)